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Letter to the Editor
Possible cohort effects in studies on oral contraceptive use
and breast cancer
Sir - In a French case-control study of breast
cancer (Le et al., 1984), we interviewed as controls
(nonmalignant disease or no disease) 403 women
aged 25 to 45 years in eight French hospitals and
clinics during the period 1981-1984. All these
women already had an experience of sexual
intercourse. The year of birth was strongly
associated with the main characteristics of oral
contraceptive (OC) use and with the age at the first
sexual intercourse (FSI).
The percentages of OC users before age 25 or
before the first full-term pregnancy were much
greater for the women born in the 1950s than for
women born earlier (Table I). The women born in
the 1950s started OC use at a younger age than the
women born earlier. They also had FSI at a
younger age and started OC use sooner after FSI
than the women born in the 1940s (Table I). These
results indicate that very deep modifications in the
lifestyles of young women occurred during the two
last decades, probably in part owing to OC
availability.
As these results reflect a phenomenon which
seems to be shared by many Western countries
(Population Reports, 1979), we wonder whether this
important cohort effect might be a source of bias in
some of the case-control studies which reported a
positive association between the duration of-early
OC use and the risk of breast cancer (Harris et al.,
1982; McPherson et al., 1983; Olsson et al., 1985;
Pike et al., 1981, 1985; Rosenberg et al., 1984).
(i) Case-control studies where the controls are
matched with the cases on the year of birth: in
Pike's studies (Pike et al., 1981, 1983) for instance,
each control was matched with the case on the year
of birth within 5 years, but the control had to be at
least as old at interview as the matched case was at
diagnosis. Thus, on the average, the controls were
born 9 months earlier (the standard deviation was
not reported), and the difference between the year
of birth of the cases and of their matched controls
was >2 years for 35% of the pairs (Pike et al.,
1981). We wonder whether this small but systematic
difference in year of birth is not sufficient to
explain a lower percentage of OC users among the
controls than among the cases.
(ii) Case-control studies where the controls are
matched on the age at interview: for these studies,
the year of birth is well controlled for only if, on
the average, the difference between the date of
interview of the cases and those of their matched
controls is not significantly different from zero. In
the study of McPherson et al., (1983), this mean
difference was not reported, and it is impossible to
verify whether the years of birth were similar for
the cases and for the controls, even if mean ages at
interview were similar. Controlling for age at
interview effectively controls year at birth when the
total recruitment period is <1 year; this will not
necessarily be the case for longer recruitment
periods such as the 15 year period used by
McPherson et al. (1983).
(iii) Unmatched case-control studies where
adjustments are made on the age at interview: in
this type of study, the year of birth is well
controlled for if, in each class used in the age
standardization, the mean year of birth is similar,
on average, for the cases and for the controls. We
do not know whether these verifications were done
in the studies using this method (Harris et al., 1982;
Rosenberg et al., 1984).
(iv) Other potential biases. The cohort effect is
not able to explain all the positive associations
between the risk of breast cancer and an early OC
use. For the studies which seemed carefully con-
trolled for the year ofbirth (Olsson et al., 1985), posi-
tive associations might be explained by the failure
to take into account all the factors associated either
with the risk of breast cancer or with OC use, like
age at FSI, socio-economic status, age at menarche,
antecedent of benign breast disease, history of
breast cancer in the family, marital status, number
of children, age at the first full-term pregnancy,
religion, body build, etc. For instance, in the
Swedish study (Olsson et al., 1985), where the year
of birth seemed carefully controlled, only two
factors were taken into account in the analysis (age
at menarche, and at first full-term pregnancy); the
distribution of other factors might be very different
between the cases and the controls.
In conclusion, when the aim of an investigation
is the study of the relationship between OC use and
the occurrence of a disease, such as breast cancer,
we advocate the careful control for both age at
interview and year of birth of the cases and the
controls because a considerable cohort effect is very
likely. In order to avoid other potential bias, we
think that all the factors known to be possibly
associated with the disease studied or with OC use
also should be taken into account in the analyses.806 LETTER TO THE EDITOR
Table I Association between year of birth, age at the first sexual intercourse, and some characteristics
of early oral contraceptive use: Study of 403 women with nonmalignant disease or no disease (age 25-
45 years)
Year ofbirth
Characteristics <1944 1945-49 1950-54 . 1955 P-value
n=189 n=107 n=86 n=21
Percentage of OC ever users before age 25 4 25 41 62 10_4a
Percentage of OC ever users before the first
full-term pregnancy 11 40 62 76 10-4a
Mean age at the first OC usec 28.2 23.9 20.1 19.0 10_4b
(s.d.) (4.9) (4.3) (2.8) (1.8)
Mean age at the first sexual intercourse 20.1 19.5 19.0 18.0 10_4b
(s.d.) (2.7) (2.4) (2.7) (1.7)
Mean delay (in years) between these two agesc 8.2 4.4 2.0 1.0 10_4b
(s.d.) (5.0) (4.4) (2.6) (1.6)
aChi-square for heterogeneity; bAnalysis of variance; cOnly for ever users.
Both the year of birth and the age at interview
were similar in our own case-control study (Le et
al., 1984), and no significant association was
observed between the main characteristics of OC
use and the risk of breast cancer when nine
potential confounding factors were taken into
account in the analysis.
Yours etc.
M.G. Le", C. Hill2, A. Kramar2 & L.H. Moulton',
'Institut National de la Sante et de la
Recherche Medicale (INSERM) Unite 287,
Institut Gustave Roussy,
94800 Villejuif, France
2Institut Gustave Roussy,
Department de Statistiques Medicales.
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